These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 32801433

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Antibodies to factor VIII in plasma of patients with hemophilia A and normal subjects.
    Batlle J, Gómez E, Rendal E, Torea J, Lourés E, Couselo M, Vila P, Sedano C, Tusell X, Magallón M, Quintana M, González-Boullosa R, López-Fernández MF.
    Ann Hematol; 1996 May; 72(5):321-6. PubMed ID: 8645745
    [Abstract] [Full Text] [Related]

  • 5. Characterization of the anti-factor VIII immunoglobulin profile in patients with hemophilia A by use of a fluorescence-based immunoassay.
    Boylan B, Rice AS, Dunn AL, Tarantino MD, Brettler DB, Barrett JC, Miller CH, Hemophilia Inhibitor Research Study Investigators, Hemophilia Inhibitor Research Study Investigators.
    J Thromb Haemost; 2015 Jan; 13(1):47-53. PubMed ID: 25354263
    [Abstract] [Full Text] [Related]

  • 6. Frequency of factor VIII (FVIII) inhibitor in haemophilia A.
    Borhany M, Kumari M, Shamsi T, Naz A, Farzana T.
    J Coll Physicians Surg Pak; 2012 May; 22(5):289-93. PubMed ID: 22538032
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Clinical evaluation of recombinant factor VIII preparation (Kogenate) in previously treated patients with hemophilia A: descriptive meta-analysis of post-marketing study data.
    Yoshioka A, Fukutake K, Takamatsu J, Shirahata A, Kogenate Post-Marketing Surveillance Study Group.
    Int J Hematol; 2006 Aug; 84(2):158-65. PubMed ID: 16926139
    [Abstract] [Full Text] [Related]

  • 15. A multicenter study of recombinant factor VIII (recombinate): safety, efficacy, and inhibitor risk in previously untreated patients with hemophilia A. The Recombinate Study Group.
    Bray GL, Gomperts ED, Courter S, Gruppo R, Gordon EM, Manco-Johnson M, Shapiro A, Scheibel E, White G, Lee M.
    Blood; 1994 May 01; 83(9):2428-35. PubMed ID: 8167332
    [Abstract] [Full Text] [Related]

  • 16. Immune tolerance in hemophilia with factor VIII inhibitors: predictors of success.
    Mariani G, Kroner B, Immune Tolerance Study Group (ITSG).
    Haematologica; 2001 Nov 01; 86(11):1186-93. PubMed ID: 11694405
    [Abstract] [Full Text] [Related]

  • 17. The spectrum of neutralizing and non-neutralizing anti-FVIII antibodies in a nationwide cohort of 788 persons with hemophilia A.
    Oomen I, Verhagen M, Miranda M, Allacher P, Beckers EAM, Blijlevens NMA, van der Bom JG, Coppens M, Driessens M, Eikenboom JCJ, Fijnvandraat K, Hassan S, van Heerde WL, Hooimeijer HL, Jansen JH, Kaijen P, Leebeek FWG, Meijer D, Paul H, Rijpma SR, Rosendaal FR, Smit C, van Vulpen LFD, Voorberg J, Schols SEM, Gouw SC.
    Front Immunol; 2024 Nov 01; 15():1355813. PubMed ID: 38455035
    [Abstract] [Full Text] [Related]

  • 18. Inhibitors among patients with hemophilia in Basra, Iraq - A single center experience.
    Taresh AK, Hassan MK.
    Niger J Clin Pract; 2019 Mar 01; 22(3):416-421. PubMed ID: 30837433
    [Abstract] [Full Text] [Related]

  • 19. FVIII and FIX inhibitors in people living with hemophilia in Cameroon, Africa: a preliminary study.
    Balôgôg PN, Tagny CT, Ndoumba A, Mbanya D.
    Int J Lab Hematol; 2014 Oct 01; 36(5):566-70. PubMed ID: 25356499
    [Abstract] [Full Text] [Related]

  • 20. Antibody response to recombinant human coagulation factor VIII in a new rat model of severe hemophilia A.
    Lövgren KM, Søndergaard H, Skov S, Weldingh KN, Tranholm M, Wiinberg B.
    J Thromb Haemost; 2016 Apr 01; 14(4):747-56. PubMed ID: 26784374
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.